temozolomide

You have access
Ko143 Reverses MDR in Glioblastoma via Deactivating P-Glycoprotein, Sensitizing a Resistant Phenotype to TMZ Treatment
SAMUEL D. LUSTIG, SRAVAN K. KODALI, SHARON L. LONGO, SOMANATH KUNDU and MARIANO S. VIAPIANO

Anticancer Research February 2022, 42 (2) 723-730; DOI: https://doi.org/10.21873/anticanres.15530
You have access
Multiparametric MRI-guided Hypofractionated Intensity-modulated Radiation Therapy With Simultaneous Integrated Boost for Glioblastoma
YUKIHIRO HAMA and ETSUKO TATE

Anticancer Research January 2022, 42 (1) 329-334; DOI: https://doi.org/10.21873/anticanres.15489
You have access
Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug – Comparison With the Chemotherapeutic Standard-of-care Temozolomide
AKIRA SUMIYOSHI, SAYAKA SHIBATA, ZHIVKO ZHELEV, THOMAS MILLER, DESSISLAVA LAZAROVA, GENOVEVA ZLATEVA, ICHIO AOKI and RUMIANA BAKALOVA

Anticancer Research December 2021, 41 (12) 6067-6076; DOI: https://doi.org/10.21873/anticanres.15426
You have access
Temozolomide and AZD7762 Induce Synergistic Cytotoxicity Effects on Human Glioma Cells
YUN CHEN, BOR-JIUN TSENG, YA-HUI TSAI and SHENG-HONG TSENG

Anticancer Research September 2020, 40 (9) 5141-5149; DOI: https://doi.org/10.21873/anticanres.14517
You have access
Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction
KEI YAMASHIRO, KAZUTAKA NAKAO, SHIGEO OHBA and YUICHI HIROSE

Anticancer Research March 2020, 40 (3) 1315-1323; DOI: https://doi.org/10.21873/anticanres.14073
You have access
Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth
MANA INADA, AKIRA SATO, MIKA SHINDO, YOHEI YAMAMOTO, YASUHARU AKASAKI, KOICHI ICHIMURA and SEI-ICHI TANUMA

Anticancer Research December 2019, 39 (12) 6743-6750; DOI: https://doi.org/10.21873/anticanres.13889
You have access
Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
TASUKU KIYUNA, YASUNORI TOME, KENTARO MIYAKE, TAKASHI MURAKAMI, HIROMICHI OSHIRO, KENTARO IGARASHI, KEI KAWAGUCHI, JOHN HSU, MANISH SINGH, YUNFENG LI, SCOTT NELSON, MICHAEL BOUVET, SHREE RAM SINGH, FUMINORI KANAYA and ROBERT M. HOFFMAN

Anticancer Research September 2019, 39 (9) 4775-4779; DOI: https://doi.org/10.21873/anticanres.13661
You have access
Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients
DIDIER AUTRAN, MARYLINE BARRIE, MONA MATTA, COLETTE MONSERRAT, CHANTAL CAMPELLO, GREGORIO PETRIRENA, CELINE BOUCARD, LAETITIA PADOVANI, ANDERSON LOUNDOU, ROMAIN APPAY, THOMAS GRAILLON, HENRY DUFOUR, DOMINIQUE FIGARELLA-BRANGER, OLIVIER CHINOT and EMELINE TABOURET

Anticancer Research February 2019, 39 (2) 1035-1041; DOI: https://doi.org/10.21873/anticanres.13210
You have access
Combination of Biochanin A and Temozolomide Impairs Tumor Growth by Modulating Cell Metabolism in Glioblastoma Multiforme
VILAS DESAI, ADITI JAIN, HOORA SHAGHAGHI, ROSS SUMMER, JAMES C. K. LAI and ALOK BHUSHAN

Anticancer Research January 2019, 39 (1) 57-66; DOI: https://doi.org/10.21873/anticanres.13079
You have access
Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma
VALENTINA SANGHEZ, MENGQING CHEN, SHAN LI, TSUI-FEN CHOU, MICHELINA IACOVINO, HENRY J. LIN, JOSEPH L. LASKY and EDUARD H. PANOSYAN

Anticancer Research May 2018, 38 (5) 2627-2634;

Main menu

User menu

Search

temozolomide

Pages